| Secondary and tertiary sulfonamides: a patent review (2008 - 2012). | |
| | |
MedLine Citation:
|
PMID: 23148584 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Introduction: Secondary and tertiary sulfonamides (R-SO(2)NR(1)R(2)) are defined by the single or double N-alkyl or N-aryl/heteroaryl substitution of the primary sulfonamide respectively. They can be obtained easily by the classical S(N)2 or nucleophile acyl substitution displacements using the appropriate synthones. Many classes of compounds used in therapy present the substituted sulfonamide groups and there is also a continuous interest in different fields such as the herbicides herein schematically reported. Areas covered: The intent of this article is to give a comprehensive overview of the most important patents in the last decade related to pathologies of great interest. All selected patents claim new compounds bearing the secondary or/and tertiary sulfonamide moiety, and state to have biological activities. The article is neither intended for detailed discussions of the sulfonamides mode of action on the specific therapeutic targets, nor for their contribution to the physicochemical properties of the molecules they are introduced into, as the scientific literature in such topics is exhaustive and in many cases, debates are still ongoing. The main fields covered are related to pathologies affecting the CNS, cardiac disorders, anti-virals, inflammation diseases, glaucoma, bone remodeling, anti-cancer, and finally a section is also dedicated to herbicides. Expert opinion: The insertion of the secondary/tertiary sulfonamide group into the organic scaffolds is chemically straightforward and not associated to particular toxicity in the cells or in the organisms. Therefore, it is possible to create large libraries of compounds, which can be tested for different diseases. As demonstrated by the patents reported in the present review, the research in medicinal chemistry, and other fields, takes big advantages as new leads are created, and might be further developed. |
| | |
Authors:
|
Andrea Scozzafava; Fabrizio Carta; Claudiu T Supuran |
Related Documents
:
|
1794914 - A clinico-pathological study of six cases of hairy cell leukaemia. 8129964 - Impending rupture of the ascending aorta due to giant cell arteritis. 8291354 - Herpesvirus mimics. a potential pitfall in endocervical brush specimens. 15871614 - Tonsillolith. case report and review of the literature. 7082894 - Non-surgical correction of a congenital lop ear deformity by splinting with reston foam. 613294 - Black grain mycetoma (maduromycosis) in horses. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2012-11-14 |
Journal Detail:
|
Title: Expert opinion on therapeutic patents Volume: - ISSN: 1744-7674 ISO Abbreviation: Expert Opin Ther Pat Publication Date: 2012 Nov |
Date Detail:
|
Created Date: 2012-11-14 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9516419 Medline TA: Expert Opin Ther Pat Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Università degli Studi di Firenze, Polo Scientifico, Laboratorio di Chimica Bioinorganica , Rm. 188, Via della Lastruccia 3, 50019 Sesto Fiorentino (Florence) , Italy +39 055 4573005 ; +39 055 4573385 ; fabrizio.carta@unifi.it. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Surgical site infections following transcatheter apical aortic valve implantation: incidence and man...
Next Document: Structural characterisation of the cyclic cystine ladder motif of ?-defensins.